Literature DB >> 7534297

Characterization of the promoter region of the human apurinic endonuclease gene (APE).

L Harrison1, A G Ascione, D M Wilson, B Demple.   

Abstract

Apurinic/apyrimidinic (AP) sites are mutagenic and block DNA synthesis in vitro. Repair of AP sites is initiated by AP endonucleases that cleave just 5' to the damage. We linked a 4.1-kilobase pair HindIII DNA fragment from the region upstream of the human AP endonuclease gene (APE) to the chloramphenicol acetyltransferase (CAT) gene. Deletions generated constructs containing 1.9 kilobase pairs to 50 base pairs (bp) of the APE upstream region. Transient transfection studies in HeLa cells established that the basal APE promoter is contained within a 500-bp fragment. The major transcriptional start site in HeLa, hepatoma (HepG2), and myeloid leukemic (K562) cells was mapped to a cluster of sites approximately 130 bp downstream of a putative "CCAAT box," approximately 130 bp 5' of the first splice junction in APE. Deletion of 5' sequences to within 10 bp of the CCAAT box reduced the CAT activity by only about half, and removal of the CCAAT box region left a residual promotor activity approximately 9%. Deletion to 31 bp upstream of the transcriptional start site abolished APE promoter activity. DNA sequence analysis revealed potential transcription factor recognition sites in the APE promoter. Gel mobility-shift assays showed that both human upstream factor and Sp1 can bind their respective sites in the APE promoter. However, DNase I footprinting using HeLa nuclear extract showed that the binding of Sp1 and upstream factor is blocked by the binding of other proteins to the nearby CCAAT box region.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7534297     DOI: 10.1074/jbc.270.10.5556

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals.

Authors:  C V Ramana; I Boldogh; T Izumi; S Mitra
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

Review 2.  Redox control systems in the nucleus: mechanisms and functions.

Authors:  Young-Mi Go; Dean P Jones
Journal:  Antioxid Redox Signal       Date:  2010-08-15       Impact factor: 8.401

Review 3.  Human apurinic/apyrimidinic endonuclease 1.

Authors:  Mengxia Li; David M Wilson
Journal:  Antioxid Redox Signal       Date:  2013-08-20       Impact factor: 8.401

Review 4.  Understanding different functions of mammalian AP endonuclease (APE1) as a promising tool for cancer treatment.

Authors:  Gianluca Tell; Damiano Fantini; Franco Quadrifoglio
Journal:  Cell Mol Life Sci       Date:  2010-08-13       Impact factor: 9.261

5.  Embryonic stem cells lacking the epigenetic regulator Cfp1 are hypersensitive to DNA-damaging agents and exhibit decreased Ape1/Ref-1 protein expression and endonuclease activity.

Authors:  Courtney M Tate; Melissa L Fishel; Julianne L Holleran; Merrill J Egorin; David G Skalnik
Journal:  DNA Repair (Amst)       Date:  2009-10-15

6.  Absolute quantitation of normal and ROS-induced patterns of gene expression: an in vivo real-time PCR study in mice.

Authors:  María José Prieto-Alamo; Juan-Manuel Cabrera-Luque; Carmen Pueyo
Journal:  Gene Expr       Date:  2003

7.  MiTF regulates cellular response to reactive oxygen species through transcriptional regulation of APE-1/Ref-1.

Authors:  Feng Liu; Yan Fu; Frank L Meyskens
Journal:  J Invest Dermatol       Date:  2008-10-30       Impact factor: 8.551

8.  ATF4-dependent oxidative induction of the DNA repair enzyme Ape1 counteracts arsenite cytotoxicity and suppresses arsenite-mediated mutagenesis.

Authors:  Hua Fung; Pingfang Liu; Bruce Demple
Journal:  Mol Cell Biol       Date:  2007-10-15       Impact factor: 4.272

Review 9.  The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapy.

Authors:  G U Dachs; I J Stratford
Journal:  Br J Cancer Suppl       Date:  1996-07

Review 10.  Disease progression mediated by egr-1 associated signaling in response to oxidative stress.

Authors:  Judith-Irina Pagel; Elisabeth Deindl
Journal:  Int J Mol Sci       Date:  2012-10-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.